<DOC>
	<DOCNO>NCT00696280</DOCNO>
	<brief_summary>Delayed emesis follow administration carboplatin-based chemotherapy despite prophylaxis standard antiemetic prophylaxis ( 5-HT3 corticosteroid ) remain clinically significant distressing problem patient cancer . The incidence delay emesis appear high woman compare men .</brief_summary>
	<brief_title>Observational Study Delayed Nausea Vomiting</brief_title>
	<detailed_description>All patient give Functional Living Index- Emesis ( FLIE ) , standardized questionnaire . This self-administered questionnaire assess impact nausea vomit patient 's functional living , include physical activity , social emotional function , ability enjoy food drink . Patients complete questionnaire 5 day follow carboplatin administration ( 24 hour , 48 hour , 72 hour 96 hour ) first third cycle chemotherapy . The questionnaire take approximately 10 minute less complete . Patients also interview trained CRA research nurse telephone 24-48 hour follow carboplatin administration order assess severity delay nausea vomit .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Patients must newly diagnose , histologically cytologically proven cancer , schedule receive chemotherapy carboplatin AUC 5 . Patients receive standard antiemetic prophylaxis prior carboplatin administration , define 5HT3 antagonist dexamethasone . We include patient whose standard care include treatment carboplatincontaining regimen treat aprepitant ( EmendÂ® ) . Age &gt; = 18 . After informed treatment involve , patient must give write consent . Entry study open men woman racial ethnic subgroup . No prior cytotoxic chemotherapy within last 5 year . Should pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>nausea</keyword>
	<keyword>vomit</keyword>
	<keyword>Carboplatin</keyword>
	<keyword>cancer</keyword>
	<keyword>delay emesis follow treatment carboplatin</keyword>
</DOC>